Hostname: page-component-7c8c6479df-hgkh8 Total loading time: 0 Render date: 2024-03-29T02:34:29.926Z Has data issue: false hasContentIssue false

Neuroleptic associated extrapyramidal symptoms

Published online by Cambridge University Press:  02 January 2018

I. Maurer
Affiliation:
University of Bonn 53105 Bonn, Germany
S. Zierz
Affiliation:
University of Bonn 53105 Bonn, Germany
H.-J. Möller
Affiliation:
University of Bonn 53105 Bonn, Germany
F. Jerusalem
Affiliation:
University of Bonn 53105 Bonn, Germany
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1995 The Royal College of Psychiatrists 

References

Burkhardt, C., Kelly, J. P., Lim, Y.-H., et al (1993) Neuroleptic medications inhibit complex I of the electron transport chain. Annals of Neurology, 33, 512517.Google Scholar
Corral-Debrinski, M., Horton, T., Lott, M. T. et al (1992) Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet, 2, 324329.CrossRefGoogle ScholarPubMed
Linnane, A. W., Marzuki, S., Ozawa, T., et al (1989) Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet, 3, 642645.Google Scholar
Pourcher, E., Baruch, P., Bouchard, R. H., et al (1995) Neuroleptic associated tardive dyskinesias in young people with psychoses. British Journal of Psychiatry, 166, 768772.Google Scholar
Schapira, A. H. V. (1994) Evidence for mitochondrial dysfunction in Parkinson's disease – a critical appraisal. Movement Disorders, 9, 125138.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.